Human CEACAM7 Antibody (2869) is a research-grade biosimilar monoclonal antibody targeting Carcinoembryonic antigen CGM2. It is a human IgG4 antibody. Reactivity: Human. Supplied as a liquid in 0.01M PBS pH 7.4. Applications: ELISA, flow cytometry, functional assays and in vivo research. Endotoxin: < 10 EU/mg. Purity: >95% purity as determined by SDS-PAGE. For research use only.